Interleukin-1 and interleukin-6 inhibition in patients with COVID-19 and hyperinflammation.

Salvatierra, JuanAomar-Millán, Ismael FranciscoHernández-Quero, José2025-01-072025-01-072021-03-08https://hdl.handle.net/10668/26010enInterleukin-1 and interleukin-6 inhibition in patients with COVID-19 and hyperinflammation.research article33782671open access10.1016/S2665-9913(21)00064-32665-9913PMC7990485http://www.thelancet.com/article/S2665991321000643/pdfhttps://pmc.ncbi.nlm.nih.gov/articles/PMC7990485/pdf